Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action

Author： Sacksteder Katherine A   Protopopova Marina   Barry Clifton E   Andries Koen   Nacy Carol A  

Publisher： Future Medicine

ISSN： 1746-0913

Source： Future Microbiology, Vol.7, Iss.7, 2012-07, pp. : 823-837

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The impact of genomics on anti-infectives drug discovery and development

By Parkinson T.  

Trends in Microbiology, Vol. 10, Iss. 10, 2002-10 ,pp. : 22-26

Elsevier

Access to resources Recommend Favorite

Understanding the mechanism of action of the anti-influenza virus drug amantadine

By Pinto L.H.   Lamb R.A.  

Trends in Microbiology, Vol. 3, Iss. 7, 1995-07 ,pp. : 271-271

Elsevier

Access to resources Recommend Favorite

Iron enhances the susceptibility of pathogenic mycobacteria to isoniazid, an antitubercular drug

By Sritharan Manjula   Yeruva Veena   Sivasailappan Sivagamisundaram   Duggirala Sridevi  

World Journal of Microbiology and Biotechnology, Vol. 22, Iss. 12, 2006-12 ,pp. : 1357-1364

Springer Publishing Company

Access to resources Recommend Favorite

Protein export systems of Mycobacterium tuberculosis: novel targets for drug development?

By Feltcher Meghan E   Sullivan Jonathan Tabb   Braunstein Miriam  

Future Microbiology, Vol. 5, Iss. 10, 2010-10 ,pp. : 1581-1597

Future Medicine

Access to resources Recommend Favorite

Cyanobacteria: potential candidates for drug discovery

By Dixit Rakhi  

Antonie van Leeuwenhoek, Vol. 103, Iss. 5, 2013-05 ,pp. : 947-961

Springer Publishing Company

Access to resources Recommend Favorite